Cargando…
Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
While the rapid advancement of immunotherapies has revolutionized cancer treatment, only a small fraction of patients derive clinical benefit. Eradication of large, established tumors appears to depend on engaging and activating both innate and adaptive immune system components to mount a rigorous a...
Autores principales: | Roy, Sumedha, Fitzgerald, Karen, Lalani, Almin, Lai, Chin-Wen, Kim, Aeryon, Kim, Jennie, Ou, Peiqi, Mirsoian, Annie, Liu, Xian, Ramrakhiani, Ambika, Zhao, Huiren, Zhou, Hong, Xu, Haoda, Meisen, Hans, Li, Chi-Ming, Lugt, Bryan Vander, Thibault, Steve, Tinberg, Christine E., DeVoss, Jason, Egen, Jackson, Wu, Lawren C., Noubade, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266786/ https://www.ncbi.nlm.nih.gov/pubmed/37317970 http://dx.doi.org/10.1172/JCI162088 |
Ejemplares similares
-
Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment
por: O’Brien, Sarah A., et al.
Publicado: (2021) -
Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
por: Kim, Jennie C., et al.
Publicado: (2022) -
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
por: Noubade, Rajkumar, et al.
Publicado: (2019) -
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
por: Shen, Shanling, et al.
Publicado: (2020) -
Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation
por: Vander Lugt, Bryan, et al.
Publicado: (2017)